Aleph Farms augmente ses capacits de production grce lacquisition de linstallation de VBL Therapeutics et au partenariat ESCO Aster
| VBLTDelisted Stock | USD 0.28 0.01 3.45% |
Slightly above 61% of Vascular Biogenics' investor base is looking to short. The analysis of current outlook of investing in Vascular Biogenics suggests that many traders are alarmed regarding Vascular Biogenics' prospects. Vascular Biogenics' investing sentiment can be driven by a variety of factors including economic data, Vascular Biogenics' earnings reports, geopolitical events, and overall market trends.
Vascular |
Aleph Farms, la premire entreprise cultiver des steaks directement partir de cellules de vache non modifies, a annonc aujourdhui quelle avait
Read at businesswire.com
 |
Vascular Biogenics Fundamental Analysis
We analyze Vascular Biogenics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vascular Biogenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vascular Biogenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Vascular Biogenics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Vascular Biogenics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vascular Biogenics stock to make a market-neutral strategy. Peer analysis of Vascular Biogenics could also be used in its relative valuation, which is a method of valuing Vascular Biogenics by comparing valuation metrics with similar companies.
Peers
Vascular Biogenics Related Equities
| XFOR | X4 Pharmaceuticals | 10.87 | ||||
| ATXI | Avenue Therapeutics | 5.71 | ||||
| RNAZ | Transcode Therapeutics | 5.02 | ||||
| ZVSA | ZyVersa Therapeutics | 4.23 | ||||
| ABOS | Acumen Pharmaceuticals | 2.48 | ||||
| ALLR | Allarity Therapeutics | 1.94 | ||||
| VRAX | Virax Biolabs | 1.87 | ||||
| DAWN | Day One | 1.13 | ||||
| HOOK | Hookipa Pharma | 0.52 | ||||
| INZY | Inozyme Pharma | 1.45 | ||||
| TERN | Terns Pharmaceuticals | 1.56 | ||||
| ZURA | Zura Bio | 1.67 | ||||
| REVB | Revelation Biosciences | 2.44 | ||||
| PHIO | Phio Pharmaceuticals | 10.47 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |